EP 249 Outcomes Following Chest Wall Perforator Flap Surgery: Eight-Year Experience at the Leeds Breast Unit

Clicks: 1
ID: 323892
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal

Ranked #277 of 432 articles by views in the british journal of surgery

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 432 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Introduction Chest wall perforator flap (CWP) provides volume replacement to cover defects post breast conserving surgery (BCS). It aims to reduce mastectomy rates and minimise the need for contralateral symmetrising surgery. Methods This is a retrospective cohort study which analysed outcomes of CWP flap surgery (January 2017-December 2024) performed at the Leeds Teaching Hospitals NHS Trust. Clinical outcome data were collected using an electronic health record system, Patient Pathway Manager (PPM). Simple summary statistics were calculated to describe demographic and outcome data. Results In total, 81 patients (median age of 56 years) underwent 82 CWP flap surgery. Histological subtypes included invasive ductal (59.8%), invasive lobular (14.6%), and ductal carcinoma in-situ (14.6%) with a median radiological tumour size of 26mm (IQR 20-35). Multifocal cancers were present in 8.4% of patients. LICAP flaps were the most prevalent (70%), followed by LICAP and LTAP (10%), MICAP (7%), AICAP (7%), and LTAP (6%). CWP flaps were utilised to cover defect post-BCS (87.8%), post-margin re-excision (7.3%), and post-mastectomy reconstruction (4.9%). The 30-day Clavien-Dindo complication rates were 17.1% (grade 2) and 2.4% (grade 3). Flap failure rate was 0. Involved margins were seen in 8.5% of patients with 1.2% eventually requiring mastectomy. With a median follow-up of 32 months, local recurrence rate was 4.9% with distant metastases rate of 3.6%. No patients required contralateral symmetrising surgery. Conclusions Chest wall perforator flaps are associated with low morbidity, low local recurrence rate, and low revisional surgery rate. This increases the range of indications for breast conserving surgery.
Reference Key
openalex_W7172481729 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Rhian Morgan, Wasif Tahir, Hamza Ikram, Brian Hogan, Baek Kim, Raj Achuthan
Journal the british journal of surgery
Year 2026
DOI
10.1093/bjs/znag087.566
URL
https://doi.org/10.1093/bjs/znag087.566
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.